These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36400344)

  • 1. Expanding therapeutic strategies for intracellular bacterial infections through conjugates of apoptotic body-antimicrobial peptides.
    Nieto Marín V; Buccini DF; Arboleda V JW; Cardoso MH; Franco OL
    Drug Discov Today; 2023 Feb; 28(2):103444. PubMed ID: 36400344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial peptides´ immune modulation role in intracellular bacterial infection.
    Duarte-Mata DI; Salinas-Carmona MC
    Front Immunol; 2023; 14():1119574. PubMed ID: 37056758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms and consequences of bacterial resistance to antimicrobial peptides.
    Andersson DI; Hughes D; Kubicek-Sutherland JZ
    Drug Resist Updat; 2016 May; 26():43-57. PubMed ID: 27180309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections.
    Abed N; Couvreur P
    Int J Antimicrob Agents; 2014 Jun; 43(6):485-96. PubMed ID: 24721232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards Robust Delivery of Antimicrobial Peptides to Combat Bacterial Resistance.
    Drayton M; Kizhakkedathu JN; Straus SK
    Molecules; 2020 Jul; 25(13):. PubMed ID: 32635310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
    Zharkova MS; Orlov DS; Golubeva OY; Chakchir OB; Eliseev IE; Grinchuk TM; Shamova OV
    Front Cell Infect Microbiol; 2019; 9():128. PubMed ID: 31114762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial extracellular vesicles contribute to antimicrobial resistance.
    Jiang B; Lai Y; Xiao W; Zhong T; Liu F; Gong J; Huang J
    PLoS Pathog; 2024 May; 20(5):e1012143. PubMed ID: 38696356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial peptides - Advances in development of therapeutic applications.
    Luong HX; Thanh TT; Tran TH
    Life Sci; 2020 Nov; 260():118407. PubMed ID: 32931796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial peptides for tackling cystic fibrosis related bacterial infections: A review.
    Bugli F; Martini C; Di Vito M; Cacaci M; Catalucci D; Gori A; Iafisco M; Sanguinetti M; Vitali A
    Microbiol Res; 2022 Oct; 263():127152. PubMed ID: 35944357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism between Host Defence Peptides and Antibiotics Against Bacterial Infections.
    Li J; Fernández-Millán P; Boix E
    Curr Top Med Chem; 2020; 20(14):1238-1263. PubMed ID: 32124698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Peptides and Cell-Penetrating Peptides for Treating Intracellular Bacterial Infections.
    Buccini DF; Cardoso MH; Franco OL
    Front Cell Infect Microbiol; 2020; 10():612931. PubMed ID: 33614528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rediscovery of antimicrobial peptides as therapeutic agents.
    Ryu M; Park J; Yeom JH; Joo M; Lee K
    J Microbiol; 2021 Feb; 59(2):113-123. PubMed ID: 33527313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taming the Devil: Antimicrobial Peptides for Safer TB Therapeutics.
    Jadhav K; Singh R; Ray E; Singh AK; Verma RK
    Curr Protein Pept Sci; 2022; 23(10):643-656. PubMed ID: 35619262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial peptides: promising alternatives to conventional antibiotics.
    Baltzer SA; Brown MH
    J Mol Microbiol Biotechnol; 2011; 20(4):228-35. PubMed ID: 21894027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation.
    Dutta P; Das S
    Curr Top Med Chem; 2016; 16(1):99-129. PubMed ID: 26139111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstructed Apoptotic Bodies as Targeted "Nano Decoys" to Treat Intracellular Bacterial Infections within Macrophages and Cancer Cells.
    Bose RJC; Tharmalingam N; Garcia Marques FJ; Sukumar UK; Natarajan A; Zeng Y; Robinson E; Bermudez A; Chang E; Habte F; Pitteri SJ; McCarthy JR; Gambhir SS; Massoud TF; Mylonakis E; Paulmurugan R
    ACS Nano; 2020 May; 14(5):5818-5835. PubMed ID: 32347709
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial peptides, conventional antibiotics, and their synergistic utility for the treatment of drug-resistant infections.
    Zhu Y; Hao W; Wang X; Ouyang J; Deng X; Yu H; Wang Y
    Med Res Rev; 2022 Jul; 42(4):1377-1422. PubMed ID: 34984699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial peptides: new drugs for bad bugs?
    Steckbeck JD; Deslouches B; Montelaro RC
    Expert Opin Biol Ther; 2014 Jan; 14(1):11-4. PubMed ID: 24206062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and challenges of antimicrobial peptide delivery strategies in bacterial therapy: A review.
    Yao L; Liu Q; Lei Z; Sun T
    Int J Biol Macromol; 2023 Dec; 253(Pt 3):126819. PubMed ID: 37709236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic-cell-penetrating peptide conjugates targeting challenging drug-resistant and intracellular pathogenic bacteria.
    Zeiders SM; Chmielewski J
    Chem Biol Drug Des; 2021 Nov; 98(5):762-778. PubMed ID: 34315189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.